Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Saphetor S.A.. (5/25/17). "Press Release: Saphetor Signs Multiple Service Agreements with University College London to Analyze Exome and Whole-Genome Sequencing Data". Lausanne.

Organisations Organisation Saphetor S.A.
  Organisation 2 University College London (UCL)
Products Product genomic software tools
  Product 2 Next Generation Sequencing (NGS) technology [about 2007/8]
Person Person Massouras, Andreas (Saphetor SA 201604 CEO + Founder before Citigroup + Credit Suisse + Salomon Brothers)
     


Saphetor, SA, a Swiss precision medicine company dedicated to advancing personalized diagnostics based on next-generation DNA sequencing, announced today a research partnership with the Exome Consortium of University College London (UCL), led by Dr. Vincent Plagnol.

As part of a series of service agreements with UCL-affiliated research groups, Prof. Michel Michaelides and his team will use Saphetor’s precision medicine platform to investigate eye disorders in patients. By partnering with world-class researchers and clinicians at UCL, Saphetor seeks to improve genetic diagnoses that will enhance prognosis counseling for patients and identify those who may be eligible for specific clinical trials.

Dr. Vincent Plagnol is a Reader in statistical genetics at the UCL Genetics Institute with a focus on translational research. His work on rare disease genetics is widely published, both in pioneering methodological advances and significant molecular discoveries. Dr. Plagnol said, “We are looking forward to working with Saphetor, as their fast turnaround and comprehensive platform will ensure timely and accurate results in our wide range of research projects.”

Prof. Michel Michaelides is a highly-cited Professor of Ophthalmology at University College London, based at the Institute of Ophthalmology, a premier vision research center. He is also a Consultant Ophthalmologist at Moorfields Eye Hospital, one of the most respected eye hospitals in the world. Prof. Michaelides said, "We are pleased to work with Saphetor, as their advanced analytical capabilities are already driving new findings in congenital eye conditions."

Andreas Massouras, CEO of Saphetor, said: “We are very honored to work with Dr. Plagnol, Prof. Michaelides, and their collaborators in the UCL Exome Consortium. We intend to accelerate novel research findings on a number of exciting projects.”


Saphetor, SA, founded in 2014, is a Swiss precision medicine company dedicated to identifying human genetic variants with improved accuracy by leveraging proprietary algorithms and expert domain knowledge. Capitalizing on the emergence of exome sequencing and whole-genome sequencing, Saphetor’s suite of services offers clinicians intuitive, data-driven solutions to make faster, more accurate diagnoses and treatment decisions. Saphetor is the creator of VarSome.com, a free and widely used genomic variant search engine with more than 33 billion data points.


Contacts

Saphetor, SA
Andreas Massouras, PhD
Chief Executive Officer
+41 21 693 8925
andreas.massouras@saphetor.com

   
Record changed: 2017-06-07

Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

More documents for Saphetor S.A.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px